Risperidone in the treatment of nonaggressive agitated symptoms related to dementia: Analysis of 617 patients in a randomized, double-blind controlled trial

被引：0
|
作者：
Mintzer, J
Ko, G
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2003年 / 15卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Pharmacologic treatment of nonaggressive agitated symptoms related to dementia: Analysis of 617 patients in a multicenter placebo-controlled study
    Mintzer, J
    Ko, G
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1073 - 1073
  • [2] Pharmacological treatment of nonaggressive agitated symptoms related to dementia: Analysis of 617 pxhents in a multicenter placebo-controlled study
    Mintzer, J
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S88 - S89
  • [3] Risk of falls in dementia patients: Analysis of a randomized, double-blind risperidone trial
    Katz, I
    Schneider, L
    Kozma, C
    Rupnow, MFT
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1067 - 1068
  • [4] A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
    Mehdi Farokhnia
    Maryam Sabzabadi
    Hossein Pourmahmoud
    Mohammad-Reza Khodaie-Ardakani
    Seyed-Mohammad-Reza Hosseini
    Habibeh Yekehtaz
    Mina Tabrizi
    Farzin Rezaei
    Bahman Salehi
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2014, 231 : 533 - 542
  • [5] A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
    Farokhnia, Mehdi
    Sabzabadi, Maryam
    Pourmahmoud, Hossein
    Khodaie-Ardakani, Mohammad-Reza
    Hosseini, Seyed-Mohammad-Reza
    Yekehtaz, Habibeh
    Tabrizi, Mina
    Rezaei, Farzin
    Salehi, Bahman
    Akhondzadeh, Shahin
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (03) : 533 - 542
  • [6] RISPERIDONE VERSUS CLOZAPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH ACUTE SYMPTOMS - A DOUBLE-BLIND, RANDOMIZED TRIAL
    HEINRICH, K
    KLIESER, E
    LEHMANN, E
    KINZLER, E
    HRUSCHKA, H
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (01): : 129 - 137
  • [7] Risperidone for the treatment of cocaine dependence: Randomized, double-blind trial
    Grabowski, J
    Rhoades, H
    Silverman, P
    Schmitz, JM
    Stotts, A
    Creson, D
    Bailey, R
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) : 305 - 310
  • [8] Risperidone treatment of resistant depression: A double-blind randomized trial
    Gharabawi, Georges
    Canuso, Carla
    Pandina, Gahan
    Bossie, Cynthia
    Kujawa, Mary
    Kosik-Gonzalez, Colette
    Turkoz, Ibrahim
    Mahmoud, Ramy
    Shelton, Richard
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S228 - S228
  • [9] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Shahin Akhondzadeh
    Raofeh Ghayyoumi
    Farzin Rezaei
    Bahman Salehi
    Amir-Hossein Modabbernia
    Azad Maroufi
    Gholam-Reza Esfandiari
    Mehrangiz Naderi
    Fariba Ghebleh
    Mina Tabrizi
    Shams-Ali Rezazadeh
    [J]. Psychopharmacology, 2011, 213 : 809 - 815
  • [10] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Ghayyoumi, Raofeh
    Rezaei, Farzin
    Salehi, Bahman
    Modabbernia, Amir-Hossein
    Maroufi, Azad
    Esfandiari, Gholam-Reza
    Naderi, Mehrangiz
    Ghebleh, Fariba
    Tabrizi, Mina
    Rezazadeh, Shams-Ali
    [J]. PSYCHOPHARMACOLOGY, 2011, 213 (04) : 809 - 815
12345